Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT5 | O14744 | 1/20 | 1.00 |
| ▸ | WDR77 | Q9BQA1 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | GAA | P10253 | 1/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 3/20 | 0.50 |
| ▸ | CA5A | P35218 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 3/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MMP2 | P08253 | 2/20 | 0.47 |
| ▸ | CA1 | P00915 | 1/20 | 0.47 |
| ▸ | MMP1 | P03956 | 1/20 | 0.47 |
| ▸ | MMP9 | P14780 | 1/20 | 0.47 |
| ▸ | MMP8 | P22894 | 1/20 | 0.47 |
| ▸ | MMP13 | P45452 | 1/20 | 0.47 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | ACHE | P22303 | 1/20 | 0.45 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29481767 | 1.00 | PRMT5 (1.00) | PRMT5WDR77KMT2AGAAHTT | |
| SCHEMBL29476299 | 1.00 | PRMT5 (1.00) | PRMT5WDR77KMT2AGAAHTT | |
| SCHEMBL336605 | 1.00 | PRMT5 (1.00) | PRMT5WDR77KMT2AGAAHTT | |
| SCHEMBL449928 | 1.00 | PRMT5 (1.00) | PRMT5WDR77KMT2AGAAHTT | |
| SCHEMBL30301224 | 1.00 | PRMT5 (1.00) | PRMT5WDR77KMT2AGAAHTT | |
| SCHEMBL28711197 | 0.90 | PRMT5 (0.81) | PRMT5WDR77KMT2AGAAHTT | |
| SCHEMBL29481804 | 0.90 | PRMT5 (0.81) | PRMT5WDR77KMT2AGAAHTT | |
| SCHEMBL29502671 | 0.90 | PRMT5 (0.81) | PRMT5WDR77KMT2AGAAHTT | |
| SCHEMBL28692108 | 0.90 | PRMT5 (0.81) | PRMT5WDR77KMT2AGAAHTT | |
| SCHEMBL8265917 | 0.88 | PRMT5 (0.79) | PRMT5WDR77KMT2AGAAHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1305 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119708491-A | Polydisulfide polymer material containing hydroxy ester group and preparation method thereof | 衢州化工新材料创新研究院 | 2025-03-28 | — | — | CN | claimed |
| CN-119330928-A | Preparation method of high-purity landiolol hydrochloride | 康普药业股份有限公司 | 2025-01-21 | — | — | CN | claimed |
| CN-115947720-B | Design, preparation and application of beta 3 adrenergic receptor anchoring probe | 南京师范大学 | 2024-03-29 | — | — | CN | claimed |
| CN-117229210-A | Decahydroisoquinoline compound and preparation method and application thereof | 中国科学院上海药物研究所 | 2023-12-15 | — | — | CN | claimed |
| CN-116211887-A | Composition for treating acid-base imbalance | 特里赛达公司 | 2023-06-06 | — | — | CN | claimed |
| CN-116178220-A | Method for preparing (2S) -2- [ [3- (methylsulfonyl L) phenoxy ] methyl ] ethylene oxide | 爱斯特（成都）生物制药股份有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-115947720-A | Design of beta 3 adrenergic receptor anchoring probe and preparation method and application thereof | 南京师范大学 | 2023-04-11 | — | — | CN | claimed |
| CN-115505062-A | Preparation method of sevelamer carbonate | 天和药业股份有限公司 | 2022-12-23 | — | — | CN | claimed |
| US-11267924-B2 | Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes | GENZYME CORPORATION (US) | 2022-03-08 | — | — | US | claimed |
| CN-113855703-A | Proton binding polymers for oral administration | 特里赛达公司 | 2021-12-31 | — | — | CN | claimed |
| WO-2007130463-A2 | AMINE CONDENSATION POLYMERS AS PHOSPHATE SEQUESTRANTS | GENZYME CORPORATION (US) | 2007-11-15 | — | — | WO | claimed |
| US-7038062-B2 | Synthesis of cyclic trithiocarbonates from epoxides | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 2006-05-02 | — | — | US | claimed |
| US-20060004210-A1 | SYNTHESIS OF CYCLIC TRITHIOCARBONATES FROM EPOXIDES | GOODYEAR TIRE & RUBBER COMPANY, THE | 2006-01-05 | — | — | US | claimed |
| EP-0930307-B1 | PROCESS FOR THE PREPARATION OF GLYCIDYL ETHERS | DAISO CO LTD (JP) | 2002-12-04 | — | — | EP | claimed |
| EP-0930291-B1 | PROCESS FOR THE PREPARATION OF 3-AMINO-2-HYDROXY-1-PROPYL ETHERS | DAISO CO LTD (JP) | 2002-08-14 | — | — | EP | claimed |
| US-6087512-A | Process for preparation of glycidyl ether | DAISO CO., LTD. (JP) | 2000-07-11 | — | — | US | claimed |
| US-6057476-A | Process for the preparation of 3-amino-2-hydroxy-1-propyl ethers | DAISO CO., LTD. (JP) | 2000-05-02 | — | — | US | claimed |
| EP-0930291-A1 | PROCESS FOR THE PREPARATION OF 3-AMINO-2-HYDROXY-1-PROPYL ETHERS | DAISO CO., LTD. (JP) | 1999-07-21 | — | — | EP | claimed |
| EP-0930307-A1 | PROCESS FOR THE PREPARATION OF GLYCIDYL ETHERS | DAISO CO., LTD. (JP) | 1999-07-21 | — | — | EP | claimed |
| WO-1988000190-A1 | OPTICALLY ACTIVE DERIVATIVES OF GLYCIDOL | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 1988-01-14 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11267924-B2 | Crosslinked polydiallymine copolymers for the treatment of type 2 diabetes | IAPP, PARP2, ADM2 | PRMT5 781/4885WDR77 1253/4885KMT2A 766/4885 |
| US-20060004210-A1 | SYNTHESIS OF CYCLIC TRITHIOCARBONATES FROM EPOXIDES | TST, CXCR6, CCR6 | PRMT5 1044/4885WDR77 847/4885KMT2A 636/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.